Super fit and unafraid of COVID? Think again, as lingering symptoms often debilitate the healthiest

Print Friendly, PDF & Email
vzouy zxfbkku r oxjdza
Credit: Washington Post/Getty Images

Like many healthy people, [57-year-old Brendan Delaney] figured his symptoms, a mild fever and a cough, would pass soon enough. Instead, he experienced debilitating aftereffects, such as fatigue and breathlessness, which many are now calling long Covid. Seven months later, he is still not back to normal.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

As a second wave of infections grows, so it follows that the number of long Covid cases is bound to increase. Although this clearly has implications for public health and the economy, it has been almost nowhere in the broader policy debate.

That narrative has focused largely on minimizing deaths and hospitalizations. But most long Covid patients weren’t hospitalized and didn’t have pre-existing conditions. This should throw some cold water on the idea of dispensing with restrictions and allowing immunity to build up among the young while shielding the vulnerable — an approach that won more adherents as lockdown fatigue set in. Going in this direction would be far more costly than many perhaps realize.

Related article:  These drugs could replace chemotherapy with fewer 'disruptive side effects'

“We need to control this virus not because of the risk that Granny may catch it and die, or your uncle may end up in ICU, but because fit, healthy people without any comorbid conditions who are young can end up having their lives wrecked,” Delaney said.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists